Drug Interactions between bedaquiline and Dextrose 5% in Lactated Ringer's Injection
This report displays the potential drug interactions for the following 2 drugs:
- bedaquiline
- Dextrose 5% in Lactated Ringer's Injection (lvp solution)
Interactions between your drugs
No interactions were found between bedaquiline and Dextrose 5% in Lactated Ringer's Injection. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
bedaquiline
A total of 597 drugs are known to interact with bedaquiline.
- Bedaquiline is in the drug class diarylquinolines.
- Bedaquiline is used to treat Tuberculosis, Resistant.
Dextrose 5% in Lactated Ringer's Injection
A total of 0 drugs are known to interact with Dextrose 5% in Lactated Ringer's Injection.
- Dextrose 5% in lactated ringer's injection is in the drug class intravenous nutritional products.
- Dextrose 5% in lactated ringer's injection is used to treat Dehydration.
Drug and food interactions
bedaquiline food
Applies to: bedaquiline
ADJUST DOSING INTERVAL: Food enhances the oral bioavailability of bedaquiline. When administered with a standard meal containing approximately 22 grams of fat (558 total Kcal), the relative bioavailability of bedaquiline increased by approximately 2-fold compared to administration under fasted conditions.
GENERALLY AVOID: Coadministration with alcohol may increase the risk of hepatotoxicity associated with the use of bedaquiline. In clinical trials, hepatic adverse drug reactions developed in more bedaquiline-treated patients than in those who received other drugs used to treat tuberculosis. In patients receiving bedaquiline or placebo in combination with other drugs used to treat multidrug-resistant tuberculosis, reversible aminotransferase elevations of at least 3 times the upper limit of normal developed more frequently in the bedaquiline treatment group [10.8%] than in the placebo group [5.7%].
MANAGEMENT: To ensure maximal oral absorption, bedaquiline should be taken with food. Patients should avoid alcohol use during treatment.
References (1)
- (2013) "Product Information. Sirturo (bedaquiline)." Janssen Pharmaceuticals
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.